These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2006757)

  • 1. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs.
    Bo M; Bonino F; Neirotti M; Gottero M; Pernigotti L; Molaschi M; Fabris F
    Angiology; 1991 Feb; 42(2):106-13. PubMed ID: 2006757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E; Truffert J; De Gennes JL
    Ann Med Interne (Paris); 1991; 142(7):505-10. PubMed ID: 1789528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patients.
    Branchi A; Rovellini A; Fiorenza AM; Sommariva D
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):345-50. PubMed ID: 7582386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ; Scott RS; Sharpe DN; Nye ER; Charleson H; French JK; White HD; Reuben S; Maling TJ; Lewis GR
    Med J Aust; 1991 Oct; 155(7):433-6. PubMed ID: 1921811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of three fibrate derivatives and of two HMG-CoA reductase inhibitors on plasma fibrinogen level in patients with primary hypercholesterolemia.
    Branchi A; Rovellini A; Sommariva D; Gugliandolo AG; Fasoli A
    Thromb Haemost; 1993 Aug; 70(2):241-3. PubMed ID: 8236126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
    Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reductions in lipid fraction plasma levels induced by simvastatin and bezafibrate. Brazilian multicenter study].
    Forti N
    Arq Bras Cardiol; 1993 Jun; 60(6):437-44. PubMed ID: 8279987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin and bezafibrate: effects on serum lipoproteins and lecithin: cholesterol acyltransferase activity in familial hypercholesterolaemia.
    Weisweiler P
    Eur J Clin Pharmacol; 1988; 35(6):579-83. PubMed ID: 3234467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
    Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined bezafibrate and simvastatin treatment for mixed hyperlipidaemia.
    Kehely A; MacMahon M; Barbir M; Wray R; Hunt BJ; Prescott RJ; Thompson GR
    QJM; 1995 Jun; 88(6):421-7. PubMed ID: 7648234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F
    Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bezafibrate and simvastatin (MK-733) in the treatment of primary hypercholesterolaemia.
    Smith DH; Neutel JM; Jankelow D; Myburgh DP
    S Afr Med J; 1990 May; 77(10):500-3. PubMed ID: 2188379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between prothrombin activation fragment F1 + 2 and serum cholesterol.
    Alessandri C; Basili S; Maurelli M; Bracaglia D; Andreozzi P; Pergolini M; Cordova C
    Haemostasis; 1996; 26(4):214-9. PubMed ID: 8872133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F; Sampietro T; Basta G; Giannasi G; Bionda A
    Minerva Med; 1995; 86(7-8):299-303. PubMed ID: 7478073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetes mellitus, hypercholesterolemia, and therapeutic prospects with simvastatin. General considerations and personal contribution].
    Pipicelli G; Pentimone F; Frustaci G; Notarangelo R; Beghè F
    Minerva Med; 1992 Dec; 83(12):819-25. PubMed ID: 1491762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL; Ambrosioni E; De Divitiis O; Di Somma S; Rosiello G; Trimarco B
    Clin Ther; 1991; 13(4):500-10. PubMed ID: 1934003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.